Cipla

Cipla Launches Initiative To Improve Access To Nebulisers For Acute Asthma Management In Primary Health Care Centres Of Rural India

Alkem Introduces Innohaler to Transform Asthma Care on World Asthma Day

Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) announced a first-of-its-kind initiative to improve access to nebulization therapy specifically for patients in the rural sections…

View Post

Cipla Recalls 7,228 Bottles Of Overactive Bladder Treatment Drug In America

Cipla the Drug company is recalling 7,228 bottles of Solifenacin Succinate tablets which is a medicine used to treat overactive bladder in the US market due to manufacturing issues. According…

View Post

Cipla Gets DCGI Nod To Import Moderna’s Covid Vaccine For Restricted Emergency Use In India: Sources

Official sources on Tuesday informed that India’s drug regulator DCGI has approved permission to Mumbai-based pharmaceutical company Cipla to import Moderna’s coronavirus vaccine for restricted emergency use in the country.…

View Post

COVID 19

Menu

Cipla

Cipla Launches Initiative To Improve Access To Nebulisers For Acute Asthma Management In Primary Health Care Centres Of Rural India

Cipla Recalls 7,228 Bottles Of Overactive Bladder Treatment Drug In America

Cipla Gets DCGI Nod To Import Moderna’s Covid Vaccine For Restricted Emergency Use In India: Sources

Everything You Need To Know About Covid Antibody Cocktail Launched In India By Cipla

Cipla To Launch RT-PCR Test Kit ‘ViraGen’ In India Partnership With Ubio Biotech

Cilpla Enters Into A Licensing Agreement Eli Lilly To Make And Sell Baricitinib To Treat Covid-19

Cipla Doubles Remdesivir Production To Meet ‘Unprecedented’ Demand

Researchers Discover Antibody ‘SC27’ Effective Against All Covid-19 Variants

MoHFW Releases ‘Health Dynamics of India 2022-23: Infrastructure and Human Resources Report’

Coal India Introduces Thalassemia Bal Sewa Yojna to Aid Stem Cell Transplants for Children at Sir Ganga Ram Hospital

Mpox in India: Minimal Risk of COVID-like Pandemic, Says Health Ministry

Delhi Government Bans Firecrackers Till January 1 to Combat Air Pollution

Mpox Scare: Centre Issues Advisory to States Amid Rising Concerns

India Confirms First Mpox Case; ‘No Immediate Risk To Public’, Says Centre

What Happens When You Get Monkeypox? India’s First Suspected Mpox Case Raises Concerns